The effect of TLR3, 7, and 9 inhibition on the DAI in the EBV DNA-exacerbated IBD mouse model was determined on a daily basis by collecting data pertaining to body weight, fecal consistency, and occult blood, and trends were observed to evaluate the severity of colitis. The gene discussed is TLR3; the disease is inflammatory bowel disease.